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ABSTRACT 
 
PLACENTAL PATHOLOGY IN INTRAUTERINE GROWTH 
RESTRICTION AND ITS RELATION TO PERINATAL      
OUTCOME 
 
 
AIMS AND OBJECTIVES:1)Histopathological examination of placenta of IUGR 
babies.2)Determine the frequency and cumulative number of placental 
abnormalities.3)To correlate the data with perinatal outcome in terms of fetal weight, 
apgar scores and perinatal mortality. 
 
METHOD OF STUDY: Analytical study for a duration of one year.Analysis of the 
placentas of IUGR babies both microscopically and macroscopically and the results are 
correlated with the perinatal outcome. 
 
RESULTS AND ANALYSIS:100 placentas of mothers who delivered IUGR babies were 
analysed.Majority of women were primigravida and in the age group of 21-30 years.45 
cases were of unexplained etiology.66 cases had abnormal Doppler flow and 34 cases had 
gross macroscopic abnormalities of placenta.Histopathological examination revealed 
multiple placental abnormalities with >3 lesions in 83 cases. Weight of placenta and 
weight of baby was significantly reduced with 3 or more lesions. The incidence of 
neonatal complications were significantly increased with multiple lesions.Apgar score at 
birth was also significantly reduced with multiple lesions. All cases (19 out of 100 cases) 
of  perinatal mortality were in the group with multiple  placental lesions. 
 
CONCLUSION: Increased frequency of placental lesions and increased number of 
lesions were significantly associated with IUGR.Increased number of placental lesions 
were commonly observed in cases with abnormal Doppler waveforms. Multiple placental 
lesions were associated with low birth weight, low placental weight, increased frequency 
of neonatal complications and increased perinatal mortality. 
INTRODUCTION 
 Fetal growth and development remains one of the most 
complex and fascinating biological processes known.  The fetus has 
been described as a perfect parasite.  Under ideal conditions 
sufficient amounts of maternal nutrients are provided across an 
uteroplacental circulation that functions efficiently to meet the 
demands of the growing fetus. 
 More than merely a conduit for the provision of oxygen and 
nutrients to the fetus, the placenta actively regulates the passage of 
substrates necessary for fetal growth and development.  Metabolic 
shifts occurs in virtually all maternal nutrients during pregnancy and 
the placenta and uteroplacental blood flow plays a key role in the 
regulation and delivery of the fuels to the fetus. 
 As gestation advances, a progressive increase in utero 
placental perfusion occurs.  The increase in uterine blood flow 
parallels increase in weight as pregnancy advances.  The appropriate 
balance and quantity of nutrients is essential for fetal and placental 
health.  Provision of nutrients from the maternal circulation into and 
through the placenta requires the co-ordinated activity of multiple 
transport proteins which function differentially in the microvillous 
membrane and basal membrane to provide and maintain the specific 
levels of nutrients necessary for normal fetal growth. 
 Intrauterine growth restriction connotes failure of the fetus to 
achieve its growth potential. While genetic abnormalities and 
chronic fetal infections may cause IUGR, most cases result from 
placental pathology.  Both in vitro and in vivo studies have 
demonstrated reduced blood volume and transport capacity for 
nutrients in the placenta of IUGR versus appropriate for gestational 
age fetus. 
 The consequences of aberrant fetal growth secondary to 
placental dysfunction extend beyond the intrauterine phase of 
existence. A variety of adult chronic illness including cardiovascular 
disease, dyslipidemia, type II diabetes, obesity are now felt to be a 
manifestation of fetal malnutrition usually resulting from placental 
changes precluding optimum function. 
 The known placental pathology of IUGR infants includes 
decrease in placental growth, maternal vasculopathy, chronic villitis, 
increased perivillous fibrin deposition, fetal thrombotic vasculopathy 
and avascular villi as its secondary features, umbilical cord anomaly, 
infarct, cytotrophoblast hyperplasia, basement membrane thickening 
etc.  Histological examination of the placentas from IUGR babies 
can supplement clinical knowledge of the cause of IUGR. 
 The present study was undertaken to investigate the pathologic 
findings regarding the placenta in IUGR babies and to correlate the 
results with the perinatal outcome.  Only through careful gross and 
microscopic pathologic examination of the placenta can an 
undiagnosed or suspected condition be identified or diagnosed.  This 
is an essential step in developing effective strategies for the 
prediction, prevention and possible treatment of growth restricted 
fetus. 
 
 
 
 
 
 
 
 
 
 
  
 
 
AIM OF THE STUDY 
 
1. Histopathological examination of placenta of  term 
IUGR babies. 
2. Determine the frequency and cumulative number of   
placental abnormalities 
3. To correlate the data with the perinatal outcome in 
terms of fetal weight,  apgar scores and perinatal 
mortality. 
 
 
 
 
 
 
REVIEW OF LITERATURE 
HISTORICAL REVIEW  
 It was not until 30 years ago that physicians first recognized 
that RUNTING – fetal growth restriction was human as well as 
animal phenomenon. 
 In 1961, WARKANY and EOLOWORKERS reported normal 
values for infant weight, length and head circumference and defined 
fetal growth restriction.  In 1962, WHO introduced the term low 
birth weight  (LBW) for all babies weighing less than 2500g as a 
single category. 
 GREVENWALD in 1963 reported that one third of LBW 
infants were mature and their small size could be explained by 
chronic placental insufficiency.  These observations led to the 
concept that birth weight was governed not only by length of 
gestation but also by rate of fetal growth. 
 In 1963 LUBCHENCO and co workers from Denwer 
published detailed comparisons of gestational age to birth weight in 
an effort to derive norms for expected fetal size and therefore growth 
at a given gestational week. 
 BATALGIA and Coworkers in 1967 then classified small for 
gestational age infants as those, whose weights were below 10
th
 
percentile for gestational age.   
 UHSER and MCLEAN (1969) proposed that fetal growth 
standards should be based on normal limits defined by plus or minus 
two standard deviations. 
 Not all infants with BW lesser than 10
th
 percentile are 
pathologically growth restricted, some are simply because of 
constitutional factors. 
 In 1969, the nomenclature ‗preterm‘ was used to indicate 
gestational age of less than 37 completed weeks (259days).  
However LBW babies include both preterm and those born at term 
but weighting less than 2500gms.  Therefore the term IUGR should 
more strictly refer to fetuses that are small for gestational age and 
display other signs of chronic hypoxia or failure to thrive.  The 
assignment of a birth weight percentile requires an accurate 
assessment of gestational age and adjustment for gender, race and 
altitude.The incidence of LBW in Indian population was estimated 
to be 28% (Tambyraja, 1992).  The incidence of IUGR in Indian 
population was estimated to be around 3-5%. 
INTRA UTERINE GROWTH RETARDATION 
 Human fetal growth is characterized by sequential patterns of 
tissue and organ growth, differentiation and maturation.  
Development is determined by maternal provision of substrate, 
placental transfer of the substrate and fetal growth potential 
governed by genome. 
 IUGR represents a continuum of various conditions that may 
ultimately result in failure of the fetus to attain its inherent growth 
potential.  Neonates weighing less than 10
th
 percentile for their 
gestational age are said to have growth restriction.  IUGR should 
strictly refer to fetuses that are small for gestational age that display 
other signs of chronic hypoxia or failure to thrive. 
 Compared with appropriately grown counterparts perinatal 
mortality in growth restricted neonates are 6-10 times greater. 
Perinatal mortality rates in growth restricted neonates as high as 120 
per 1000 for all cases of IUGR and 80 per 1000 after exclusion of 
anomalous infants have been reported.  Perinatal mortality in cases 
with abnormal Doppler wave form ranges between 40 – 70%.  
Incidence of IUGR estimated to be around 3-10%.  
 
Classification of IUGR 
1.  Depending on the time of onset and pathological process 
A.  Type I / Symmetric IUGR  :   20 – 30% 
- Growth inhibition in early pregnancy from 4-20 weeks 
- Reduced number of cells in fetus 
- Overall decreased growth potential 
- HC and AC, length, weight below the 10
th
 percentile for 
gestational age  
- Ponderal Index – Normal 
B -  Type II  / Asymmetric IUGR :  70 -80% 
- Later than type I – after 28 weeks of gestation 
- Cell size is reduced 
-        Brain sparing effect 
- HC - Normal   FL - Normal 
- AC and Ponderal index low 
C -  Intermediate IUGR :   5 – 10% 
- Combination of type 1 and type 2 
- Onset early in second trimester 
- Both cell number and cell size reduced 
 
II.Based on Origin of IUGR :       
A. Intrinsic  :  Fetal conditions that cause IUGR  
   Intrauterine infections, chromosomal disorder 
   Congenital malformation. 
B. Extrinsic  :  Growth restriction due to elements outside the         
fetus. 
    Placental conditions 
    Maternal diseases 
C.      Combined 
    Both intrinsic and extrinsic factors operate. 
D.         Idiopathic  : 
    Etiology unknown. 
AETIOLOGY 
FETAL CAUSES : 
A. Chromosomal abnormality including trisomy 13,18,21 
autosomal deletions and ring chromosomes. 
B. Congenital infections:  Rubella, cytomegalovirus, varicella 
and HIV, Malaria, Toxoplasma and Trypanosoma. 
C. Structural anamolies:  Central nervous system, 
cardiovascular, gastrointestinal, genitourinary, musculo 
skeletal. 
D. Genetic causes:  Agenesis of pancreas, Galactosemia, 
Phenylketonuria, congenital lipodystrophy. 
PLACENTAL CAUSES : 
 Single umbilical artery 
 Abnormal placental implantation 
 Vilamentous umbilical cord insertion 
 Bilobed placenta 
 Placental hemangiomas 
Microscopic lesions such as thrombosis, infarction, deciduitis, 
vasculitis, edema, chorioamnionitis. 
MATERNAL CAUSES : 
Maternal characteristics : 
 Extremes of maternal age, nulliparity, low maternal weight, 
H/o IUGR in previous pregnancy. 
Maternal diseases :  Hypertension, renal diseases, autoimmune 
disorders, hyperthyroidism  and long term insulin dependent 
diabetes, respiratory diseases, long standing type 2 DM with 
vasculopathy. 
 Maternal smoking 
 Alcohol and Drugs – Cocaine and opiates 
 Thrombophilias – Antiphospholipid antibody syndrome 
 Nutritional Deficiency – Famine, Inflammatory bowel diseases 
FETAL AND MATERNAL BLOOD CIRCULATION 
SYSTEMS 
 The placental circulation brings into close relationship two 
circulation systems :  The maternal and the fetal. The supply of 
blood to the placenta is influenced by various factors, especially the 
arterial blood pressure, uterine contractions, tobacco abuse, 
medication and hormones. Placental blood flow is increased at term 
and accounts to 500 ml / min  (80% of uterine perfusion). 
Fetal circulation system  
 The villous capillaries are branches of umbilical vessels.  Fetal 
blood comes via the two umbilical arteries and leaves the placenta 
through a single vein. Their supply amounts to approximately 40% 
of the fetal heart blood volume per minute. 
  The blood pressure in the arteria umbilicalis amounts to 50 
mmHg and blood flows through finer vessels that cross the chorionic 
plate to the capillaries in the villi where the arterial blood pressure 
falls to 30 mm Hg.  In the umbilical vein, the pressure is 20mm Hg.  
The pressure in the fetal vessels and their villous branches always lie 
over that of intervillous space.  This protects the fetal vessels from 
collapse. 
 
Maternal Circulation system :  Utero placental circulation : 
 During pregnancy, the uterine circulation constantly adapts in 
order to be adequate for the growing metabolic needs of the embryo 
via the spiral arteries that come from the uterine arteries. Maternal 
blood gets into the intervillous space in a region delimited by 
anchoring villi.  Subsequently the blood leaves the intervillous space 
via the uterine veins that are arranged in the periphery of intervillous 
space. 
 The flow of placental blood amounts to 600 cm3/mt and the 
pressure in the spiral arteries to 70mmHg in the intervillous space.  
The pressure falls to only 10mmHg.  The blood in the intervillous 
space is exchanged 2-3 times per minute. 
 
 
Intervillous haemodynamics : 
 Volume of blood in mature placenta   :   500 ml 
 Volume of blood in intervillous space :  150 ml 
          Blood flow in intervillous space   :   500 – 600 ml / min 
Pressure in intervillous space  
 During uterine contraction : 30 – 50 mm Hg 
 During uterine relaxation : 10 – 15 mm Hg 
Pressure in uterine artery : 70 – 80 mmHg 
Pressure in draining uterine vein : 8 mm Hg 
 
 
About 120 – 200 spiral arteries open into the intervillous space 
by piercing the basal plate randomly at numerous sites.  Normally 
there is cytotrophoblastic invasion of spiral arteries initially upto the 
intradecidual portion within 12 weeks of pregnancy.  The musculo 
elastic media is destroyed and replaced by fibrinoid material.  There 
is a secondary invasion of trophoblast between 12-16 weeks 
extending upto radial arteries within the myometrium.  The spiral 
arteries are converted into large bore uteroplacental arteries.  The net 
effect is funnelling of the arteries which reduces the pressure of 
blood to 70-80mm Hg before it reaches the intervillous space.  It 
thus increases the blood flow. 
The venous blood of the intervillous space drains through the 
uterine veins which pierce the basal plate randomly like the arteries.  
This concept of uteroplacental circulation is based on the studies of 
Ramsay and Coworkers (1963). 
REGULATION OF FETAL GROWTH  
 Defining disorders of growth requires relating a given 
achieved growth to an expected growth.  The primary interest in 
assessing fetal growth is to avoid complication associated with a 
fetus poorly grown due to uteroplacental insufficiency.  The most 
important consequence of fetal comprimise is perinatal death, 
principally antepartum still birth. 
Factors regulating fetal growth  
1. Endocrine regulation of fetal growth 
2. Placental regulation of fetal growth 
3. Genomic imprinting and fetal growth 
Endocrine regulation of fetal growth 
 Fetal growth is critically regulated by Insulin like growth 
factors (IGFs).  IGFs are of 2 types IGF -1 and IGF 2.  The effects of 
IGFs are influenced by six distinct IGF binding proteins (IGFBP).  A 
number of IGFBP proteases exist such as pregnancy associated 
plasma protein– A (PAPP –A), a protease for IGFBP-4 and IGFBP-
5.  Many associations have been described between cord blood, 
amniotic fluid and maternal serum levels of components of IGF 
system and fetal growth. 
Placental regulation of fetal growth  
 The placenta is clearly crucial for fetal growth as it provides 
all the substrates for fetal growth and performs gaseous exchange in 
fetal life.  Some of the associations between IGF system proteins and 
eventual birth weight are placentally derived components, such as 
PAPP-A, as IGFs are also important in controlling placentation.  
Placental function tests demonstrate association with eventual fetal 
growth.  Many complications of pregnancy associated with poor 
placental function may be due to failure of the ‗second wave‘ of 
trophoblast invasion in the second trimester.  There are associations 
between both the size of fetus in the first trimester of pregnancy and 
maternal levels of PAPP-A and the eventual birth weight of the 
baby. 
Genomic imprinting and fetal growth  
 Key genes of IGF system are imprinted.  Genomic imprinting 
is the selective inactivation of a gene in the conceptus in relation to 
maternal or paternal copy.  Genomic imprinting is a feature of 
placental mammals.  In fetal life this is manifested in the control of 
fetal growth.  The key role of placental IGF system is the fact that 
IGF-2– a stimulator of placental invasion is paternally imprinted and 
type-2, IGF receptor which degrades IGF–II is maternally imprinted.  
Aberrant expression of imprinted genes may lead to fetal over 
growth or intrauterine growth restriction. 
 
 
Pathophysiology of IUGR  
             Compared with an average for gestational age fetus, the 
IUGR fetus has altered body composition (including decreased body 
fat, total protein, whole body DNA and RNA, glycogen and free 
fatty acids) altered distribution of weight among organs and altered 
body proportions. Approximately, 20% of IUGR infants are 
symmetrically small with a relative proportionate decrease in many 
organ weights.  Eighty percent are asymmetrically small, with 
relative sparing of brain weight, compared to liver or thymus. 
 In asymmetric IUGR, brain weight is decreased only slightly 
compared with that of AGA controls, due to decrease in brain cell 
size. Cerebral abnormalities include decreased myelination, 
decreased utilization of metabolic substrates other than glucose and 
altered protein synthesis.  Deprivation in early pregnancy is 
associated with less cerebral sparing and diffusely slowed brain 
growth. 
 Symmetric IUGR infants have proportionately small brains 
due to decreased number of brain cells.  The cause is more often a 
genetic disorder or infection leading to early severe nutritional 
deprivation.  The thymus is small with an average decrease of 25%. 
The decrease may explain the decreased cellular immunity seen in 
IUGR infants. 
 Liver is frequently affected, atleast partly because of 
diminished glycogen deposits. The liver also may have functional 
metabolic abnormalities manifested by cord blood and neonatal 
serum chemistries.  Such abnormalities reflect the underlying cause 
for decreased size. 
 Blood flow to the lungs may be decreased lessening the 
pulmonary contribution to amniotic fluid volume responsible for 
oligohydramnios.  Decreased pulmonary blood flow is associated 
with accelerated functional pulmonary maturity. 
 Renal blood flow is reduced in asymmetric IUGR pregnancies.  
Diminished glomerular filtration rate may contribute to 
oligohydramnios. 
MATERNAL CONTRIBUTION TO ABERRANT FETAL 
GROWTH PHYSICAL ENVIRONMENT 
 Certain normal mothers are prone to repeated delivery of SGA 
infants, the recurrence rate may be 25% to 50%.  These women may 
themselves were SGA, the possibility of non genetic inter 
generational transmission of a physical regulator of fetal growth.  
These women exert a restraint on fetal growth by unknown regulator 
related to their own stature, previous nutritional status or uterine 
capacity. 
 Another risk for IUGR is maternal failure to expand their 
plasma volume during pregnancy leading to reduced placental 
weight and hematocrit. 
 Maternal genetic factors have a major effect on fetal growth 
related  in part to uteroplacental function.  Paternal factors have less 
effect on fetal growth.  The uterine capacity may itself place a 
constraint on optimal fetal growth. 
Maternal nutrition  
 Prepregnancy weight and pregnancy weight gain are two 
important independent variables that affect fetal growth.  
Underweight mother and those affected with malnutrition deliver 
infants with diminished birth weight.  Weight gain during pregnancy 
in non obese patients correlates significantly with fetal birth weight.  
Poor weight gain as early as 16 weeks gestation may predict low 
birth weight. 
 
 
 Calculating the pregravid body mass index (BMI) 
       Prepregnancy weight (kg) ×100 
 BMI =   
Height
2
 (m) 
 
 It helps the clinician to determine the target for pregnancy 
weight gain, which may reduce the risk of IUGR.  An underweight 
women (BMI<18.5) may require a pregnancy weight gain of 12.5 to 
18 kgs, a normal weight woman (BMI -18.5 to 24.9) need a weight 
gain of 11.5 to 16 kgs and a overweight woman (BMI- 25 to 29.9) 
require a weight gain of 7 to 11.5 kgs, whereas obese women BMI 
(> 30) may need a weight gain of only 6 kgs. 
 The effects of maternal nutritional status on fetal growth are 
minimal during the first trimester of pregnancy. As fetal growth 
accelerates, the requirements for fetal growth increases and may not 
be sufficiently provided by an inadequate maternal diet. 
 Decreased caloric uptake below critical caloric needs may 
result in diminished fetal growth.  A threshold of 1500 kcal/day 
augmented fetal weight when the mother was in positive caloric 
balance. 
 Certain metabolic aberrations are associated with suboptimal 
growth.  Mothers with excessively low fasting blood glucose values 
and those whose blood glucose levels are not sufficiently elevated 
after an OGTT are at risk of delivering an SGA infant. 
Chronic diseases  
 Chronic maternal hypertension caused by primary renal 
parenchymal diseases (nephritis) or extrinsic parenchymal disorders 
such as essential hypertension alters fetal growth and well being.  
Pregnancy induced hypertension may affect uteroplacental  
perfusion and fetal growth as determined by Doppler flow velocity 
waveforms of uterine artery.  Preeclampsia is characterized by 
defective endovascular trophoblastic invasion, reduced perfusion of 
the intervillous space, necrotizing atherosis and decreased 
trophoblastic invasion of decidual spiral arteries.  In pregnancies 
complicated by eclampsia, fetal growth deviates from expected norm 
from 32 weeks onwards. 
 Diminished fetal weight gain also results from maternal 
hypoxia due to severe cyanotic congenital heart disease, sickle cell 
anaemia and diminished environmental oxygen saturation present at 
high altitude. 
Drugs  
 Drugs causing IUGR may be due to direct cellular cytotoxicity 
or by reducing maternal appetite [ex. Amphetamines, 
Antimetabolites, cocaine, Bromides, Ethanol, heroin etc) 
 Cigarette smoking during pregnancy reduces eventual fetal 
birth weight and related directly to number of cigarettes smoked.  
Birth weight at term is reduced to an average of 170gms if >10 
cigarettes used per day and use of more than 15 per day may reduce 
weight by 300 gms. 
 Nicotine and subsequent catecholamine release may produce 
uterine vasoconstriction and fetal hypoxia. Carbon monoxide and 
cyanide may cause direct effect. 
PLACENTAL DETERMINANTS  
 Optimal fetal growth depends on efficient function of placenta 
as both a nutrient supply line and an organ of gaseous exchange.  
Placental functional integrity requires additional energy production 
because placental oxidative metabolism may equal that of fetus.  
Large energy requirements is essential to maintain fetal growth 
promoting roles which includes active transport of aminoacids, 
synthesis of protein and steroid hormones and support of placental 
maturation and growth. 
 Placental growth parallels to that of fetus, towards term there 
is a decline in the rate of placental weight gain than in the rate of 
weight gain by fetus.  The placental villous surface  area continues to 
increase with advancing gestational age, simultaneously the 
syncytiotrophoblast layer continues to thin and vascularisation of the 
terminal villi continues to improve.  Functionally, urea clearance is 
enhanced towards term suggesting that permeability and diffusing 
distance improve as placenta approaches towards term. 
 Birth weight has been correlated to placental weight and 
villous surface area suggesting macroscopic and microscopic events 
are related to optimal placental function.  Uterine blood flow and 
thus placental oxygen or nutrient transfer may be reduced if maternal 
blood volume contracts. Failure to expand plasma volume, which 
normally occurs in later half of gestation has been associated with 
IUGR.  These high risk women may be identified through an 
elevated hemoglobin level. 
 When placental insufficiency occurs, there may be a functional 
failure of placenta as a respiratory or nutritive organ or both.  
Placental insufficiency associated with maternal nutritional 
deficiency has more than one effect on fetal growth.  In addition to 
diminished fetal substrate provision, placental metabolism will be 
altered directly.  Diminished placental growth will adversely affect 
total nutrient transfer, where as reduced placental production of 
chorionic somato mammotropin will attenuate maternal mobilization 
of fuels to the fetus.  Reduced placental energy production and 
protein  synthesis limits active transport of aminoacids and facilitate 
transport of glucose. 
FETAL DETERMINANTS  
 Optimal fetal growth depends on adequate provision of 
substrates, their effective placental transfer and inherited regulatory 
factors within fetal genotype. 
Factors affecting fetal growth  
A.  Chromosome disorders associated with IUGR 
 1. Trisomy 13, 18, 21 
 2. 4p syndrome 
 3. 5p syndrome 
 4. Triploidy,  XO 
B.  Metabolic disorders 
 1. Agenesis of pancreas 
 2. Congenital absence of Islets of langerhans 
 3. Congenital lipodystrophy 
 4. Maternal renal insufficiency 
C.  Syndromes associated with IUGR  
 1. Bloom syndrome 
 2. Dwarfism 
 3. Meckel – Gruber syndrome 
 4. Mobius syndrome 
D.  Congenital infections associated with IUGR 
 1. Rubella 
 2. Cytomegalovirus 
 3. Toxoplasmosis 
 4. Malaria, syphilis                                                             
 
DIAGNOSIS 
History  
 Patients with significant medical or obstetric history such as 
chronic hypertension, severe toxaemia of pregnancy, chronic renal 
disease, twins and advanced insulin dependent diabetes are at high 
risk of having an IUGR fetus.  The obstetric history of prior delivery 
of IUGR baby is also important.  Other risk factors are BMI < 19 
and maternal smoking, congenital uterine anomalies. 
 
 
Clinical assessment  
A. Weight gain :  Relatively insensitive sign of inadequate fetal 
growth.  Normal weight gain in pregnancy is around 10-12 
kgs.  Weight gain below 6 kg should give a suspicion of 
IUGR. 
B. Symphysiofundal Height  
Maternal uterine fundus is objectively measured and charted 
during each antenatal visit.  After 20 weeks gestation, the 
normal symphysial fundal height in centimeters 
approximates the number of weeks of gestation, after 
appropriate allowances for maternal height and fetal 
gestation.  The sensitivity ranges from 60% - 85% and 
positive predictive value are 20% - 80%. 
Biochemical 
 Four hormone or protein markers measured in maternal sera 
early in second trimester are associated with IUGR.  These include 
estriol, human placental lactogen, HCG and alpha fetoprotein.  
Clinically maternal serum alpha fetoprotein is the most useful 
marker of abnormal placentation. 
 
Ultrasound assessment 
 USG biometry is the diagnostic tool of choice for the 
documentation of fetal growth disorders.  Accurate assessment of 
gestational age is a necessary first step so that percentile ranks of 
absolute measurements can be derived.  Because fetal growth 
restriction has many underlying etiologies that affect the timing of 
onset and fetal features, no single sonographic method is adequate 
for diagnosis. 
DIRECT MEASUREMENTS 
Biparietal Diameter : 
 It is a poor tool for detection of IUGR.  The physiologic 
variation with advancing gestation is high, cranial growth delay as a 
result of insufficient nutrition is relatively late and the shape of the 
cranium is readily altered by external forces.  (eg. Oligohydramnios, 
breech presentation) 
Head circumference : 
 It is better than BPD in predicting IUGR.  It is not subjected to 
variability as is BPD.  The cephalic index, which is the ratio of BPD 
to occipitofrontal diameter is age dependent and helps in identifying 
dolicocephaly and brachycephaly. 
Transverse Cerebellar diameter[ TCD]: 
 Upto 25 weeks, the measurement of TCD in cm equals 
gestational age in weeks.  Serial measurements have more predictive 
value than a single measurement. 
Abdominal circumference (AC) : 
 AC and fetal weight are the most accurate ultrasound 
parameters for diagnosis of IUGR.  AC has the highest sensitivity 
and greatest negative predictive value for sonographic diagnosis of 
IUGR.  An increase in fetal AC of less than 10mm in 14 days has a 
sensitivity of 85% and specificity of 74% for identification of IUGR.  
Fetal weight can be calculated by a variety of formula (Hadloc, Ott, 
Shepherd) 
MEASUREMENT RATIOS  
Head to Abdomen Ratio HC / AC : 
 In a normally growing fetus, the HC / AC ratio exceeds 1.0 
before 32 weeks.  It is approximately 1.0 at 32-34 weeks.  After 34 
weeks, it falls below 1.0.  An HC / AC ratio > 2 SD above the mean 
is predictive of IUGR.  Serial measurement of AC and estimation of 
fetal weight are more diagnostic of fetal growth restriction. 
 
Femur length to Abdomen circumference Ratio : 
 FL / AC ratio is gestational age independent. Normal value is 
22 at all gestational ages from 21 weeks till term.  FL / AC ratio 
greater than 23.5 suggests IUGR. 
Amniotic fluid volume : 
 Type 2 IUGR is associated with oligohydramnios. AFI is 
determined by adding the depths of largest vertical pockets in the 4 
quadrants of the uterus.   
Incidence of IUGR in Oligohydramnios 
Vertical pocket Incidence of IUGR 
> 2cm 6% 
1-2 cm 20% 
< 1 cm 39% 
 
 Placental dysfunction and fetal hypoxemia may result in 
decreased perfusion of fetal kidneys and subsequent oliguria and 
oligohydramnios. 
Fetal Ponderal Index  
 Degree of fetal wasting is judged by fetal ponderal index.  It is 
estimated by dividing the estimated fetal weight by third power of 
femur length (weight / length3).  PI below 10
th
 percentile is taken as 
IUGR.  Its normal value is 8.325 ± 2.5.  An FPI of 7.0 or less is 
considered abnormal. 
Doppler Ultrasonography  
 The most widely used arterial indices are pulsatility index,  
systolic to diastolic ratio and resistance index. 
    Peak Systolic- end diastolic peak velocity 
Pulsatility index :              Time averaged maximum velocity 
 
Resistance Index RI :       Peak Systolic - end diastolic peak velocity 
                     Systolic peak velocity 
Systolic to Diastolic Ratio :     Systolic Peak velocity 
                               Diastolic peak velocity 
As the vascular impedance of placenta increases, fetal 
protective mechanism are triggered which are reflected in Doppler 
studies.  The temporal sequence of Doppler changes are :  Amniotic 
fluid index and umbilical artery pulsatility index are the first to 
become abnormal followed by changes in MCA velocimetry, aorta 
Doppler study, ductus venosus wave form and inferior venacava 
Doppler. 
Umbilical Artery : 
 In IUGR, there is a chronological process characterized by 
increased umbilical artery resistance S/D ratio, absent end diastolic 
flow, reverse end diastolic flow.  Perinatal mortality increases 
significantly in fetuses with absent end diastolic flow (9-41%) and 
reversed end diastolic flow (33-73%) in the umbilical artery. 
Middle Cereberal Artery : 
 Increased resistance to blood flow in the placenta results in a 
redistribution of the cardiac output to favour cardiac and cerebral 
circulations.  This results in an increased flow in the diastolic phase 
with reduced S/D ratio.  The cerebral placental ratio (ratio between 
MCA PI and umbilical artery PI) is considered to be more sensitive 
predictor to detect redistribution of blood flow. 
Ductus venosus : 
 In IUGR, when circulatory compensation of the fetus fails, the 
DV wave form shows absent or reverse blood flow during atrial 
contractions. Pulsation of umbilical vein may be seen.  The perinatal 
mortality ranges from 63 – 100%, hence fetus should be delivered 
before the development of absent or reversed diastolic flow. 
 
 
 
 
PLACENTA 
Placenta is a temporary organ for the development of embryo 
and fetus.  The human placenta is discoid, hemochorial, deciduate. 
 Placenta is developed from 2 sources. 
1. Fetal -   chorion frondosum 
2. Maternal -  Decidua basalis 
 It begins at 6
th
 week and completed by 12
th
 week. 
Term placenta  
 It is a circular disc with diameter of 15 – 20 cm and thickness 
of 2.5 cm at its centre.  It is spongy and weigh around 500 gm and 
the placentary index is 1 : 6 at term.  At term four – fifth of placenta 
is of fetal origin.  The maternal portion amounts to less than 1/5
th
 of 
placenta constituting only the decidua basalis and blood in the 
intervillous space. 
Villous structure of placenta 
 These arise from the chorionic plate and extends to the basal 
plate.  From the main stem villi – primary, secondary, tertiary villous 
are formed.  Functional unit of placenta is fetal cotyledon or 
placentome, derived from a major primary stem villous.  Functional 
subunit of placenta is a lobule, derived from tertiary stem villi.  The 
total villous surface area for exchange varies between 4-14 square 
meters.  The villi functions to anchor the placenta to the decidua and 
majority are free within the intervillous space and are called nutritive 
villi. 
Functions of Placenta  
1. Transfer of nutrients and waste products: Between mother and 
the fetus by simple diffusion, facilitated diffusion, active 
transfer and endocytosis / exocytosis. 
2. Metabolic functions :  Metabolises the hormones and enzymes 
necessary to maintain pregnancy. 
3.  Respiratory function :  Intake of O2 and output of CO2 takes 
place by simple diffusion across fetal membrane.  The oxygen 
supply to the fetus is at the rate of 8 ml / kg / min and achieved 
with a cord blood flow of 165 – 330 ml / min. 
4. Excretory function :  Waste products from the fetus such as 
urea, uric acid, creatinine are excreted by simple diffusion. 
5.  Nutritive function : 
 Glucose  -  Facilitated diffusion 
 Lipids     -   Denovo synthesis and direct transfer 
 Aminoacids -  Active transport 
 Water and electrolytes -  Simple diffusion 
  [Na+,  K+, Cl-] 
  Ca2+, P, Fe   -  Active transport 
6.  Enzymatic function: 
 Diamine oxidase – inactivates circulatory pressure amines 
 Oxytocinase   -  Neutralise the oxytocin 
 Phospholipase A2   Synthesise arachidonic acid 
7.  Barrier function: 
 Protective barrier to the fetus against noxious agents such as 
virus, protozoa and certain drugs 
8.  Immunological function : 
 Placenta probably offers immunologic protection against 
rejection of fetal allograft. 
RATIONALE FOR PLACENTAL EXAMINATION 
Gross placental examination is important for 2 reasons. 
1. Placental gross abnormalities may provide clinicopathologic 
correlations with obstetric events [  ex :  very small placental size 
and infarct strongly suggest chronic placental ischaemia, while 
ruptured membranous vessels may explain fetal death or anaemia]. 
2. To identify regions that should be studied further by histology. 
A recent analysis of obstetric malpractice claims concluded 
that many more neurologically impaired infant claims could be 
successfully defended if placenta specimens were available for 
evaluation at the time a claim is made. 
Gross Examination of Placenta  
General Appearance  
Shape :   Variations include bilobation, Trilobation, Accessory / 
Succenturiate lobation, placenta membranacea. 
 Although the collaborative perinatal study suggests that some 
of these abnormal placental shapes may be associated with adverse 
outcomes little literature exists in this area. 
Weight : 
 Abnormally small placenta are most commonly associated 
with chronic uteroplacental hypoperfusion and fetal growth 
retardation.  Exclusively heavy placentas may signify diabetes, 
severe villous edema,  fetal hydrops and congenital syphilis.  
Placental weights above the 90
th
 or below the 10
th
 percentile for 
gestational age should be noted in pathology report. 
 
Conditions associated with small 
placentas (< 10
th
 percentile) 
Conditions associated with large 
placentas (>90
th
 percentile) 
Chronic placental underperfusion 
Fetal growth retardation 
Chromosomal disorders 
Congenital malformations 
Possible neurologic outcome      
such as cerebral palsy 
Maternal diabetes 
Fetal hydrops 
Congenital syphilis 
Villous edema 
Chorangiosis 
Beckwith Wiedeman syndrome 
 
Colour: 
Dull, white opaque appearance in acute chorioamnionitis. 
Brown discoloration of membrane and chorionic plate –   
Hemosiderin deposition secondary to chronic abruptio placenta. 
Slimy green appearance – meconium staining. 
UMBILICAL CORD AND MEMBRANE  
Umbilical cord 
1.  Insertion :   Marginal insertion in 5% of placenta. 
2.  Distribution of vessels :  Velamentous insertion -  1%. 
3.  Twist :  Untwisted cord suggest prolonged fetal inactivity 
            (muscular disorder, fetal entrapment) 
4.  Length :  Short cord  (< 40 cm)– Prolonged fetal inactivity. 
                     Excessively long cord-fetal death. 
5.  Color :  Yellow green – meconium exposure . 
  Diffuse brown red - fetal retention after death. 
6.  Knots :  True knots if tight and constricting - fetal death. 
7.  Vessel number :  Single umbilical artery (1%)  - numerous  
 fetal malformations, fetal aneuploidy and fetal death. 
MEMBRANES  
1. Distribution :  Circummarginate / circumvallate. 
2. Integrity :  Amniotic band syndrome - Asymmetric fetal                        
abnormalities 
3. Opacity and color :  Greenish color – Meconium staining. 
     Red brown – Hemosiderin. 
4. Odour :    Foul odour reflect infection. 
 
PLACENTA OF IUGR FETUSES 
Placental Size  
 With the introduction of prenatal ultrasound examination, it 
has been reported that unduly small placental volume during the 
second trimester is strongly associated with subsequent low birth 
weight.  (Thame et al 2001, 2004). 
 The reduced placental size is due to reduced uteroplacental 
blood flow due to incomplete or insufficient trophoblastic invasion 
of the spiral arteries in the placental bed.  When placentation is 
abnormal, trophoblastic invasion is largely confined to the decidual 
layer with absent or incomplete changes in the myometrial portion of 
spiral and radial arteries causing increased vascular resistance and 
decreased blood flow to the intervillous space, restricting the 
maternal capacity to provide oxygen and nutrients to the fetus. 
Immuno Histochemical markers : 
 Placental apoptosis does appear increased in pregnancies 
affected by fetal growth restriction (Ishihara et al 2002) and 
associated with decreased expression of inhibitors of apoptosis.  
Cellular proliferation rate in these placentas using 
immunohistochemical technique have reported both normal and 
reduced proliferation (Chen et al 2002). 
 Expression of VEGF (Vascular Endothelial growth factor) and 
its receptor in placentas complicated by fetal growth restriction has 
been reported as both increased  (Helske et al 2001) and unchanged 
(Tse et al 2001).  Endothelin I immuno reactivity appears reduced in 
the capillary endothelial cells of villi from growth restricted 
pregnancies. 
 The proto oncogenes c-jun and c-fos m-RNA expression were 
significantly over expressed in IUGR fetus.  Conflicting findings 
exist about the expression of IGF and its receptors.  Fetal growth 
restriction is associated with reduced concentration of both placental 
and cord blood leptin, decreased placental Interleukin – 10 (IL-10) 
m- RNA expression, whilst (IL-8) m – RNA expression is increased. 
 Production of matrix metallo proteinases and placental growth 
hormone may be reduced in pregnancies complicated by inadequate 
fetal growth whereas expression of TGF – B is relatively unaffected. 
GROSS ABNORMALITIES  
 Gross variations in the shape of placenta, circumvallate 
placenta, reduced placental size and reduced placental weight and a 
dull white opaque appearance due to chorioamnionitis or meconium 
staining may be found in placenta of IUGR. 
Maternal floor Infarction : 
 Infarcts are best recognized by their gritter, granular 
consistency, which is related to villous composition.  Infarcts are 
commonly located closed to the maternal fetal interface, reflecting 
their pathogenesis in diseased maternal spiral arterioles.  Recent 
infarcts are dark red, older infarcts are brown red to tan to yellow 
white colour. 
Extensive Perivillous Fibrin Deposition : 
 Placental cut surface shows marbling of the placental 
parenchyma by tan white fibrinous material in a nodular to diffuse 
pattern. 
Thrombosis of Fetal arteries : 
 Fetal thrombosis is found in approximately 40% of placentas 
of fetus with IUGR.  Several distinctive pattern of placental disease 
indicative of fetal thrombosis may be seen including i) Thrombi in 
large fetal vessels  2) Clusters of avascular terminal villi.  
Hemorrhagic endovasculitis : 
 Thrombi may be grossly visualized as dilated dark red vessels 
(recent) or shrunken tan white sometimes calcified vessels (remote). 
Chorangiomas : 
 Chorangiomas are located adjacent to the fetal surface of 
placenta.  Usually contiguous with the chorionic plate or large stem 
villi. 
Gross placental abnormalities associated with abnormal 
childhood mental, neurological, psychological outcome 
Placental abnormality    Abnormal outcome 
Short umbilical artery    MR, Neuro, CP 
Single umbilical artery    MR, Neuro 
Velamentous cord insertion   Psych 
Green coloured umb. Cord (meconium) Psych 
Long umbilical cord    Psych 
Opaque fetal surface(chorioamnionitis) MR,neuro, Sz 
Circumvallate membrane insertion  Neuro 
Meconium stained amniotic fluid  CP, MR, Sz 
Absent Subchorionic fibrin   MR, neuro, CP 
Succenturiate lobe    MR, Sz 
Maternal floor infarct    MR, Neuro 
Bipartite / Tripartite shape   MR, Neuro, Psych 
Diffuse chorionic fibrin             Psych, Neuro 
MR  -  Mental retardation 
Neuro -   various neurological disorders – Abnormal speech,  
  poor motor co-ordination 
CP  -   Quadriplegic, paraplegic, hemiplegic cerebral palsy 
Sz  -   Seizures 
Psych :   Behaviour disturbances, attention deficit disorder  
  (adapted from Narye) 
 
Histological abnormalities : 
Placental pathology in IUGR 
1. Chronic placental Ischaemia (30%) 
2. Chronic villitis 
Infectious villitis (TORCH) 
Non specific villitis 
Massive chronic intervillositis 
3. Fetal vasculopathy (40%) 
Fetal thrombosis 
Hemorrhagic endovasculitis 
Diffuse villous fibrosis 
4. Increased perivillous fibrin 
5.      Vascular malformation  (mesenchymal dysplasia) 
The fetal side of the placenta may show changes secondary to 
or independent of the alterations in the maternal side.  The most 
common lesions found on the fetal side of the placenta are increased 
number of syncytial knots, obliteration of arteries in the tertiary stem 
villi, reduction in the vascularity of terminal villi and stromal 
fibrosis. 
Thrombosis in maternal side of the placenta coexists with 
alteration in uteroplacental blood flow, clotting in the spiral arteries 
or the intervillous space results in placental infarcts that reduce the 
number of functioning villi and affects the supply of oxygen and 
nutrients to the fetus. 
In massive perivillous fibrin deposition the intervillous space 
is occupied by fibrin and villi embedded in the fibrinous mass are 
non functional.  This lesion strongly suggest the possibility of 
maternal thrombophilia. 
Maternal floor infarction is characterized by massive 
deposition of fibrin in the maternal floor of the placenta encasing the 
contiguous villi that become atrophic / necrotic.  It is associated with 
IUGR in > 50% cases.  This condition frequently reoccurs in 
successive pregnancies. 
Lymphocytic and histiocytic infiltration of the villi are 
markers for chronic villitis, a nonspecific lesion frequently 
associated with vascular lesions in the maternal or fetal side of the 
placenta.  Chronic villitis occurs in approximately 8% in normal 
pregnancies but incidence increases 3-4 fold in cases of IUGR. 
 Hemorrhagic endovasculitis is associated with poor pregnancy 
outcome and histologically characterized by the presence of 
numerous extravascular erythrocytes infiltrating the villi.  Both 
hemorrhagic endovasculitis and chronic villitis are frequently 
present in placentas from women with preeclampsia. 
Clotting and thrombosis may be found in fetal side of the 
placental circulation.  Fetal thrombotic vasculopathy occur 
simultaneously with infarcts or decidual vasculopathy in the 
maternal side of the placenta.  Fetal vasculopathy has a strong 
association with poor pregnancy outcome.  There is an association 
between the placental lesion and thromboembolic lesions in fetal 
brain. 
 
 
 
 
 
 
 
 
Subclassification of Placental pathologies in IUGR  
Subclassification Placental Findings 
 
 
 
Vascular or  
Ischaemic pathology 
Congested villi 
Villous hemorrhage (Intravillous) 
Villous infarction (gross and microscopic) 
Intervillous thrombosis 
Decidual vasculopathy 
Decidual hemorrhage 
Abruption 
Fetal surface vessel / umbilical vessel 
thrombosis 
Inflammatory pathology Villitis 
Villous maturation disorder Delayed / Advanced 
Dysmaturity / Variable 
Chorangiosis 
Other isolated abnormalities Isolated membrane abnormality 
Amnion nodosum / meconium deposition 
Isolated cord edema / isolated villous edema 
Mild perivillous fibrin deposition 
COMPLICATIONS OF IUGR: 
 
 •Fetal complications Stillbirth, hypoxia/acidosis,  malformations  
 
•Neonatal complications Hypoglycemia, hypocalcemia, 
  
Hypoxia & acidosis, hypothermia, meconium aspiration , 
 
Polycythemia, hyperbilirubinemia, sepsis, low APGAR score 
 
congenital malformations, apneic spells, intubation 
 
 sudden infant death syndrome 
 
•Long term complications Lower IQ, learning & behavior 
  
problems, major neurological handicap seizures, cerebral  
 
Palsy, mental retardation. 
  
•Perinatal mortalility 1.5-2 times increased OR.  
 
 
Placental pathology and Perinatal outcome : 
 Abnormal uteroplacental vasculature and chronic 
uteroplacental insufficiency, coagulation related pathology in the 
uteroplacental, intervillous and/or fetoplacental vasculature and 
chronic inflammatory lesions may be the primary disease process 
related to the placental pathology of IUGR.  The incidence of 
neurologic morbidities in IUGR infants was 1-7 fold higher than 
normal cases.  Although the cause of IUGR pregnancies is 
heterogenous, careful clinicopathologic correlations in individual 
cases are necessary in the interpretation of placental lesions of IUGR 
and the total burden of several placental lesions may be more 
important than a single histologic feature.  Total number of placental 
lesions >3 was associated with an increased risk for IUGR. 
MATERIALS AND METHODS 
Study Design : 
 Analytical study 
Source of Data : 
 The study was carried out in the Department of Obstetrics and 
Gynaecology, GRH, Madurai.  100 placentas of IUGR babies were 
collected during the study period from October 2010 – November 
2011. 
Inclusion Criteria : 
  Placentas of pregnant women who delivered term IUGR 
babies.  (Birth weight less than10th percentile according to standard 
normal curves). 
Exclusion Criteria : 
1. Known congenital anomaly in fetus 
2. Twin pregnancies 
3. Prematurity 
4. Unreliable LMP without first trimester scan 
Method of study : In this study, mothers who delivered IUGR 
babies were enrolled as cases. For each case details as mentioned in 
the structured proforma were collected after delivery. 
 Ultrasound parameters including fetal biometry, estimated 
fetal weight, amniotic fluid index and Doppler USG of the umbilical 
artery were noted. 
 Immediately after delivery, the newborn is weighed and the 
birth weight percentiles were determined by previously published 
normal curves by Alexander GR in 1996.  The placentas were 
weighed and macroscopic examination done which includes the 
placental diameter, thickness, colour, calcification and other 
abnormalities noted. 
 The placentas are sent to Pathology department for 
histopathological examination by a senior pathologist. 
 Placental histologic data includes decidual vasculopathy, fetal 
thrombotic arteriopathy, chorangiosis, acute inflammation, chronic 
villitis and intervillous thrombosis. 
 The frequency and cumulative number of placental 
abnormalities in IUGR babies were determined and the relationship 
to perinatal outcome was determined in terms of fetal weight, Apgar 
scores and perinatal mortality. 
 
 
  
RESULTS AND OBSERVATIONS 
 Total of 100 cases of IUGR were included in the study.  The 
observations and results of the study are presented in the following 
pages. 
Table – 1 
Age distribution in the study (years) 
Age No.of cases Percentage 
< 20 15 15 
21 – 30 80 80 
> 31 5 5 
Total 100 100 
 
 80% of patients are in the age group 21-30 years, and only 5% 
above 31 years. 
 
 
 
 
  
 
 
15
80
5
0
10
20
30
40
50
60
70
80
P
E
R
C
E
N
T
A
G
E
< 20 21 – 30 > 31
AGE IN YEARS
AGE DISTRIBUTION
No.of cases
 
 
 
 
 
 
 
 Table – 2 
Parity Distribution  
Gravida No.of cases Percentage 
1 48 48 
2 31 31 
3 17 17 
4 and above 4 4 
Total 100 100 
 
  48% of them were primigravida. 
Table – 3 
Distribution based on Socio economic status 
Socio economic 
status 
No.of cases Percentage 
V 58 58 
IV 30 30 
III 8 8 
II 4 4 
I 0 0 
Total 100 100 
 
 58% of patients belong to class V socioeconomic status. 
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 Table – 4 
Distribution of cases based on Etiology 
Etiology No.of cases Percentage 
Idiopathic 45 45 
PIH 28 28 
Anemia 14 14 
Heart Disease 4 4 
Placenta previa 2 2 
Chronic maternal disease 4 4 
Miscellaneous 3 3 
Total 100 100 
 
 45% of cases are due to unknown etiology, followed by pre 
eclampsia 28%, 14% due to anaemia, 4% due to heart disease. 
 Chronic maternal disorders include 2 cases of chronic 
hypertension,1 case of chronic nephritis,1 case of panniculitis. 
 The miscellaneous group comprised the following etiologies 
i)connective tissue disorders (1) ii) Inflammatory bowel disease (1), 
iii) Bronchial asthma (1). 
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 Table – 5 
Based on Pregnancy weight gain 
Weight gain No.of cases Percentage 
< 5 kg 1 1 
6 – 10 kg 87            87 
> 11 kg 12 12 
Total 100 100 
 
 About 87% of patients had weight gain of  6-10 kgs, only 12% 
had weight gain  > 11 kgs.  
Table – 6 
Distribution of cases based on Amniotic fluid Index 
AFI No.of cases Percentage 
< 5 51 51 
5 – 10 36 36 
11 – 15 13 13 
Total 100 100 
 
About 51% had oligohydramnios AFI < 5 cm, and 36% 
had reduced liquor AFI : 6-10 cm. 
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Table – 7 
Distribution of cases based on Umbilical artery  
Doppler changes 
 
Umbilical artery 
Doppler changes 
Frequency Percentage 
Normal flow 34 34 
Reduced flow 34 34 
Absent flow 28 28 
Reversal of flow 4 4 
Total 100 100 
 
  As shown in the table and pie chart, out of 100 cases 34 
had normal flow, 34 had reduced flow, 28 had absent diastolic flow.  
The rest 4 had reversal of flow. 
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Table – 8 
Distribution of cases based on Macroscopic Abnormalities 
 
Macroscopic 
Abnormalities 
Frequency Percentage 
Present 34 34 
Absent 66 66 
Total 100 100 
 
 As shown in the table and pie chart, 66% had normal 
macroscopy, the remaining 34% had one or more of the following 
abnormalities.  Calcification, unduly small placenta, necrosis, 
retroplacental clots. 
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Table – 9 
Based on Microscopic abnormalities of placenta 
Placental histopathology Frequency Percentage 
Placental Infarcts 60 60 
Decidual vasculopathy 42 42 
Syncytial knots 58 58 
Chorioamnionitis 33 33 
Stromal fibrosis 38 38 
Chronic villitis 18 18 
Hemorrhagic endovasculitis 15 15 
Increased Trophoblastic 
proliferation 
15 15 
Increased perivillous fibrin 9 9 
Basement membrane 
thickening 
16 16 
Calcifications 13 13 
 
 As per the table and pie chart placental infarcts were found in 
60%, syncytial knots in 58%, decidual vasculopathy in 42%, the 
remainder being chorioamnionitis 33%, stromal fibrosis 38%, 
chronic villitis 18%, hemorrhagic endovasculitis 15%, basement 
membrane thickening 16%, calcification 12%. Increased 
trophoblastic proliferation in 15% of cases. 
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Table – 10 
Based on number of placental lesions 
No.of Lesions Frequency Percentage 
1 6 6 
2 11 11 
3 39 39 
≥4 44 44 
Total 100 100 
 
  Among 100 cases, 44 had more than or equal to 4 
placental lesions, 39 had 3 lesions, 11 had 2 lesions and only 6 had 
single lesion. 
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Table – 11 
Comparison of umbilical artery Doppler waveforms with 
placental pathology 
 
Doppler waveforms No.of placental lesions 
1 2 3 4 Total 
Abnormal flow 1(1%) 2(2%) 27(27%) 36(36%) 66 
Normal flow 5(5%) 9(9%) 12(12%) 8(8%) 34 
Total 6 11 39 44 100 
 
Increased number and frequency of placental pathologies were 
more commonly observed in cases with abnormal Doppler 
waveforms when compared with normal Doppler waveforms with 
difference being statistically significant with p <0.001. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
5
2
9
27
12
36
8
0
5
10
15
20
25
30
35
40
N
o
.o
f 
c
a
s
e
s
1 2 3 4
Placental Lesions
Comparison of umbilical artery Doppler waveforms with placental pathology
Abnormal flow Normal flow
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Table-12 
Abnormal Doppler waveforms in relation to the number of  
Placental lesions 
 
 
 
Out of the 66 cases with Doppler abnormalities, 27 cases had 3 
lesions and 36 of them had four or more lesions. (p < 0.001) 
significant. 
 
 
 
 
 
No of 
placental 
lesions 
Reduced 
diastolic 
flow 
Absent flow Reversal of 
flow 
Total 
1 1(1.5%) - - 1 
2 1(1.5%) - 1(1.5%) 2 
3 13(19.6%) 13(19.6%) 1(1.5%) 27 
≥4 19(28.7%) 15(22.7%) 2(3%) 36 
Total 34 28 4 66 
Table – 13 
Distribution of cases based on type of Delivery 
Mode of Delivery Frequency Percentage 
Vaginal 46 46 
Instrumental 4 4 
LSCS 50 50 
Total 100 100 
 
  As mentioned above, 46% had vaginal delivery, 4% had 
instrumental delivery, 50% were delivered by LSCS. 
 
Table – 14 
Based on weight of the placenta  
Weight of placenta Frequency Percentage 
 ≤350 51 51 
350 – 400 39 39 
≥400 10 10 
Total 100 100 
 
As  stated above 51% of the study group had placental weight 
<350 grams, 39% had placental weight between 350-400 grams. 
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Table 15 
Distribution based on weight of the baby 
 
Weight of baby Frequency Percentage 
<1.5 kg 6 6 
1.5-2kg 51 51 
2.1-2.5kg 43 43 
>2.5kg - - 
Total 100 100 
 
43 babies had birth weight between 2.1-2.5 kg (<10
th
 
percentile), 51 babies had birth weight between 1.5-2 kg (<5
th
 
percentile), the remaining 6 babies had birth weight less than 1.5 kg. 
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Table 16 
Comparison of Birth weight and placental weight in relation to 
No.of placental lesions. 
No.of lesions Birth weight 
Mean(grams) 
Placental weight 
Mean(grams) 
1 2340 410 
2 2130 400 
3 2060 350 
≥ 4 1820 330 
 
The total cumulative number of placental lesions had a 
significant correlation with placental birth weight and fetal weight. 
As the number of lesions increases the birth weight and the placental 
weight decreases, the relation being statistically significant  with      
p value <0.001. 
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 Table – 17 
Fetal outcome in relation to number of placenta lesions 
No.of 
lesions 
Apgar 
(Median) 
 
Neonatal complications 
1‖ 5‖ HIE RDS MAS Sepsis 
1 7 8 0 0 0 1(1.2%) 
2 6 8 0 3(3.8%) 2(2.5%) 1(1.2%) 
3 5 7 4(5.1%) 12(15.3%) 10(12.8%) 1(1.2%) 
>4 2 4 4(5.1%) 18(23%) 18(23%) 4(5.1%) 
Total   8 33 30 7 
 
Increased number of placental lesions was associated with a 
decreased fetal apgar score and increased frequency of neonatal 
complications.Babies with single placental lesion had a 1 min apgar 
score of 7 compared to 2 for babies having 4 or more lesions. 
Similarly the rate of neonatal complications increased significantly 
when number of lesions were more than 4(p<0.001) 
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 Table 18 
Number of placental lesions in relation to perinatal mortality 
No of placental 
lesions& 
frequency 
Doppler 
abnormalities 
Still 
birth 
Admission in 
NICU 
Neonatal 
death 
1 6% 1 0 6 
(min-2days    
Max-3 days) 
0 
2 11% 2 0 11 
(min-2 days    
Max-5 days) 
0 
3 39% 27 0 39 
(min-4 days   
Max-21days) 
5 
≥4 44% 36 3 41 
(min 5 days   
Max-28 days) 
11 
Total 100 66 3 97 16 
Out of 100 cases,  83 cases had 3 or more placental 
abnormalities.Out of 66 cases with Doppler abnormalities,63 cases 
had 3 or more placental lesions.3 babies were still born who had >4 
placental lesions, 16 cases of neonatal death of which 5 babies  had 3 
lesions and 11 babies had >4 placental lesions. 
 Figure - 1 
Gross examination of the placenta showing yellow  
areas of infarction 
 
 
Figure No. 2 
Hypertrophic decidual vasculopathy 
 
 
 Figure No. 3 
Microscopic examination showing calcification 
 
 
Figure No. 4  
 Thrombotic vasculopathy 
 
 Figure No. 5 
 Stromal fibrosis 
 
Figure No. 6 
 Chorioamnionitis 
 
 
 
 
 
 
 
 
  
 
 
Figure No. 7 
Villitis of unknown etiology 
 
 
 
 
 
 
 
SUMMARY 
IUGR is related to a variety of clinicopathologic factors 
including maternal, uterine and fetal factors. Preeminent among the 
maternal factors is the restriction of growth due to uteroplacental 
insufficiency. Recent studies of placental examination of IUGR 
pregnancies provide good evidence for the occurrence of distinctive 
structural and histological abnormalities. 
 In this study, majority of cases were primiparous women 
(48%) in the age group of 21-30 years(80%).A study by Robert 
M.Kliegman et al showed that low socioeconomic status have been 
associated with poor fetal  nutrition. About 58% of patients belong 
to class V socioeconomic status and 30% belong to class IV 
socioeconomic status. 
 In this study, 45% cases of IUGR are of unexplained etiology 
and PIH contributed to 28%.Park et al,Kim et al,Chun et al 2002 
showed that IUGR groups had higher incidence of oligohydramnios 
than controls.Our study proved similar results. 
 In this study, 34% of cases had macroscopic abnormalities of 
placenta.  The placentas from pregnancies complicated by IUGR 
tend to be smaller than those from normal uncomplicated 
pregnancies. (Thame et al 2001, 2004, Khadija qamar et al). In the 
present study, the placental weights were significantly lower 
especially in those with 3 or more number of placental lesions. 
Macara et al worked on the structural analysis of placental villi 
from growth restricted pregnancies with abnormal umbilical artery 
Doppler waveforms.  They found that the terminal villi from the 
IUGR cases were smaller in diameter than those of controls and had 
increased syncytial nuclei, thickened basal lamina and increased 
stromal deposition of collagen and fibrin. In our study, the 5 main 
histopathological lesions documented are placental infarcts (60%) 
which are mainly due to ischaemia followed by syncytial knots in 
58% of patients, decidual vasculopathy in 42% of patients, stromal 
fibrosis in 38% and chorioamnionitis  (33%). 
 The overall incidence of infarction is increased in placentas 
growth restricted infants.  (Bjoro et al, Suska et al, Salafia et al) and 
Laurini et al have claimed that infarction is the only placental lesion 
that correlates with growth restriction. In our study, 60% of babies 
had placental infarct. 
 The finding of ischemic type changes in many placentas from 
pregnancies with Idiopathic intrauterine growth restriction suggests 
that there is diminished maternal blood flow in such cases and this 
has been confirmed by Doppler studies of uteroplacental circulation.  
(Trudinger et al, Mc Cowarr et al, Jacobson et al, Beroley et al, 
Schulmann et al, Iwata et al, Nicolaides et al).  There is a clear 
correlation with abnormal Doppler wave form and the presence of 
ischemic type of changes in the placenta.  In our study, increasing 
number of placental lesions had significant correlation with 
abnormal Doppler wave forms. 
Placental pathology and its relation to perinatal outcome 
  Liaquat All minnas et al,Muhammad yunas khan et al: 
2009 showed that mean birth weight was lower in fetus with 
multiple placental abnormalities. Majority of  babies (57%) had low 
birth weight with mean birth weight of 2.06 kg when there are 3 
lesions and a mean of 1.82 kg when there are 4 or more lesions. 
  A study by Rose M. Viscardi et al and Chen Cin J. Sun 
et al has proved that severity of placental abnormalities expressed as 
the cumulative number of lesions is a significant risk factor for 
IUGR and increased perinatal mortality.  Our study proved the 
similar results.  
 Increased number of placental lesions were associated 
with a decreased fetal apgar score and increased frequency of 
neonatal complications.Babies with single placental lesion had a 1 
min apgar score of 7 compared to 2 for babies having 4 or more 
lesions. Similarly the rate of neonatal complications increased 
significantly when number of lesions were more than 4(p<0.001) 
  The perinatal mortality increased with number of 
placental lesions. All the 3 cases of stillbirth were with multiple 
lesions. There were 16 cases of neonatal death with 3 or more 
lesions. 
  Assessment of placental pathology is an invaluable tool 
in determining the pathophysiology behind the growth restriction.  It 
is also useful in determining the underlying mechanisms leading to 
pregnancy complications and for guiding future investigations.
 The consequences of aberrant fetal growth secondary to 
placental dysfunction extend beyond the intrauterine phase of 
existence.  A variety of adult chronic illness including 
cardiovascular disease, dyslipidemia, type II diabetes, obesity are 
now felt to be manifestations of fetal malnutrition usually resulting 
from placental changes precluding optimum function.  Therefore 
placental examination may represent a means of investigating the 
intrauterine past to explain the present condition of the neonate.   
The results of this study provide new evidence for the relationship 
between intrauterine events, reduced growth velocity and postnatal 
consequences.  Specific patterns of placental pathological findings 
may be predictive of specific adverse neonatal outcomes. 
 
           Over the past 10-15 years medicolegal implications of 
placental pathologic examination have been emphasized.  In 
obstetric malpractice ligations involving perinatal death, neurologic 
damage or mental impairment, the presence of chronic placental 
abnormalities (such as infarcts, small placental size, membranous 
cord insertion, maternal decidual vasculopathy, chorangiosis, 
nucleated fetal RBCS etc) may suggest that fetal damage occurred 
antenatally rather than perinatally.  A recent analysis of obstetric 
malpractice claims concluded that ‗many more neurologically 
impaired infant claims could be successfully defended if placenta 
specimens were available for examination at the time a claim is 
made‘. 
 
CONCLUSION 
1. Histopathological examination of placenta in cases with IUGR 
revealed pathological changes like infarction, inflammation and fetal 
thrombotic vasculopathies. 
2. Increased frequency of placental lesions and increased number of 
lesions were significantly associated with IUGR. 
3. Increased number of placental lesions was commonly observed in 
cases with abnormal Doppler waveforms compared with normal 
Doppler waveforms with difference being statistically significant 
with p value < 0.001. 
4. Multiple placental lesions were associated with low birth weight, 
low placental weight and increased frequency of neonatal 
complications and increased perinatal mortality.(p<0.001) 
5. It is well recognized that all institutions do not have pathologist with 
experience in doing placental pathology.  If protocols are instituted 
such that placentas from all cases of IUGR are subjected to 
histopathological examination, it will allow a more complete 
understanding of the pathophysiology of fetal growth restriction, 
knowledge of risk of additional complications to the mother and the 
neonate and the risk of recurrence in subsequent pregnancies. 
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PROFORMA 
PLACENTAL PATHOLOGY IN IUGR AND ITS RELATION TO 
PERINATAL OUTCOME 
 
Case No. :      IP No.   : 
Name  :      D.O.Admission: 
Age  :      D.O. Delivery  : 
Husband‘s Name :      
Occupation : Husband   Educational  Husband 
   Wife       Wife 
Socioeconomic Status : 
   Monthly Income :   < 5000   /   5000 – 8000  /  8000-10000 / > 10000 
Presenting Complaints : 
  Safe confinement / Pains / Draining PV / Bleeding PV 
Menstural H/o : Cycles  :     Regular / Irregular 
Marital H/o  : Married since  ________  month 
    Consanguineous / Non consanguineous 
Present Obstetric H/o   : Obstetric Code  :  Primi 
 LMP :    Booked at GRH / Booked outside 
 EDD :    Pregnancy weight gain  : 
First Trimester scan EDD  Risk Factors    : 
Past Obstetric H/o   : 
 LCB  : 
 H/o PIH / GDM / Prolonged pregnancy / Malnutrition 
 Mode of Delivery:  LN / Outlet / Vacuum  / LSCS 
Outcome : 
 Baby weight 
 Term / Preterm / IUGR 
 Still born / living / dead 
Past H/o 
 Preeclampsia :  Cardiac disease class 3,4  : 
 Chronic HT  :  Connective tissue disorders: 
 Chronic renal disease:  Hemoglobinopathies : 
 Diabetes mellitus :  Sickle cell Anaemia : 
 Epilepsy  :  Multiple gestations  : 
 Chronic lung diseases:  Living at high altitude : 
Personal H/o 
 Husband Smoker : 
 Tobacco chewing : 
 Alcohol ingestion : 
 Drug intake  : 
 Drug addiction : 
General Examination  
 Height  :    PR : 
 Weight  :    BP : 
 Pallor   :    Thyroid : 
 Cyanosis  :    Breast : 
 Clubbing  :    CVS  : 
 Pedal edema :    RS  : 
Obstetric Examination : 
 Estimated gestational age : 
 Height of the uterus  : 
 Symphysiofundal height  : 
 Abdominal girth   : 
Investigations : 
 Hb %    :                     
 Blood Grouping & Typing: 
 Random blood sugar : 
      Urea : 
   Creatinine : 
 Urine Albumin  : 
  Sugar   : 
  Deposits  : 
 PPTCT   : 
USG 
 Gestational age  : 
 AFI    : 
 EFW    : 
 FL / AC   : 
 HC / AC   : 
 Congenital anamolies : 
 Placental grading  : 
 Doppler   : 
 Type of IUGR  : 
Labour Induction : 
 Spontaneous / ARM / Gel / Syntocinon / Misoprostol 
Intranatal course : 
 1
st
 stage   : Uneventful /prolonged 
 2
nd
 stage   : Uneventful / prolonged 
Mode of Delivery   
 Labour Natural  : 
 Forceps / Vaccum  :    Indication : 
 LSCS    :    Indication : 
Outcome of Delivery : 
Live birth  / Still birth :                                                                                    
Sex    : 
 Apgar  1‖   :    Apgar  5‖: 
 Weight of the baby : 
 Length of baby  : 
 Ponderal Index  : 
 Meconium   : Thin / Thick 
 IUGR    : Symmetrical / Asymmetrical  
Neonatal Complications : 
 Birth asphyxia  : 
 Jaundice   : 
 Sepsis   : 
 Admission in NICU : 
 Ventilatory support : 
 Neonatal Death  : 
Macroscopy 
 Colour :     Calcification : 
 Texture :     Atrophy   : 
 Dimension :     RP Clots : 
 Weight :     Abnormalities : 
 Thickness :     Placentary Index : 
Microscopy : 
 Chorioaminionitis   : 
 Placental Infarcts   : 
 Perivillous fibrin Deposits : 
 Chronic villitis   : 
 Decidual vasculopathy  : 
 Stromal fibrosis   : 
 Syncytial knots   : 
 Hemorrhagic Endovasculitis : 
 Increased Trophoblastic proliferation : 
 Basement membrane thickening: 
 Placental lesion score 
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27 8321 2 2 1 1 2 3 1 2 2,3,4,7 4 3 1 2 1 1 
28 19239 2 2 2 1 2 1 3 1 1,3,7 3 3 2 2 1 1 
29 9151 2 1 4 2 2 2 1 1 1,3,4,7 4 3 1 2 1 1 
30 10734 2 1 2 3 2 2 1 2 1,2,3,5,7 4 3 2 2 1 1 
31 18627 2 4 1 3 2 1 3 1 1,2,3,4,5,7 4 3 1 2 1 1 
32 16400 2 1 1 2 2 2 1 2 1,4 2 3 3 2 1 1 
33 15596 2 1 2 1 3 1 3 1 1,3,4 3 3 2 3 1 1 
34 21016 2 3 1 1 3 2 1 2 1 1 1 2 3 1 2 
35 14653 2 1 2 1 3 1 2 1 1,2,3,7 4 1 1 3 1 1 
36 13920 2 2 3 1 2 3 3 2 2,3,4,5,7 4 3 1 2 2 0 
37 31363 2 1 1 2 2 2 1 2 1,2,5 3 3 2 3 1 2 
38 14422 2 1 2 1 3 1 2 2 1,2,3,4,7 4 3 1 3 1 1 
39 8865 1 1 1 3 2 3 3 1 1,2,3,7 4 3 2 2 1 1 
40 9761 2 1 1 3 2 2 2 2 1,2,3,7 4 3 2 3 1 1 
41 9343 2 2 4 2 2 1 4 1 2,4, 2 3 2 3 1 1 
42 9905 2 2 1 3 2 2 3 2 1,2,3,4,7 4 3 1 2 1 1 
43 11303 2 1 2 1 2 3 2 2 1,2,3,7 4 3 1 3 1 1 
44 11487 2 1 3 1 2 3 2 1 1,2 2 3 2 2 1 1 
45 12067 2 1 2 1 2 1 2 1 1 1 3 3 3 1 2 
46 12107 2 2 3 1 2 3 3 2 2,3,4,5,7 4 3 2 3 1 1 
47 12235 2 1 1 2 2 2 1 2 2,3,7 3 3 1 3 1 1 
48 15689 2 3 2 2 3 1 2 1 1,3,5 3 1 2 3 1 1 
49 15462 2 4 1 3 1 2 1 2 1 1 1 3 3 1 2 
50 18243 2 4 1 3 2 2 3 2 1,2,4,7 4 1 1 2 1 1 
51 20064 2 3 2 3 2 1 3 1 2,4,7 3 1 1 3 1 1 
52 20023 2 3 1 4 2 1 3 1 2,4,7 3 1 3 2 1 1 
53 20300 1 3 1 1 2 3 1 2 1,7 2 1 3 3 1 1 
54 19059 2 3 1 1 2 3 1 2 3,7 2 1 3 2 1 1 
55 26300 2 3 1 1 2 3 1 2 4,6 2 1 2 3 1 1 
56 20306 2 1 1 2 2 1 2 2 3,4,7 3 1 1 2 1 2 
57 15603 2 2 1 3 2 2 2 2 2,4,7 3 1 2 2 1 1 
58 21071 2 3 1 1 2 1 2 2 3,4,5,7 4 1 1 3 1 1 
59 20274 2 2 1 7 2 2 2 1 4,6,7 3 1 2 1 1 1 
60 19867 2 2 1 3 2 2 1 2 2,7 2 1 1 2 1 2 
61 20129 1 2 1 1 2 1 3 1 2,4,7 3 1 1 3 1 1 
62 20755 1 2 2 1 3 2 1 2 4,7 2 1 3 2 1 2 
63 20588 2 2 2 1 3 2 1 2 1,2 2 1 2 3 1 2 
64 18467 2 1 1 2 2 2 1 2 1,4 2 3 3 3 1 2 
65 7402 3 2 1 1 2 1 3 1 1,3,5 3 3 1 2 1 1 
66 16420 2 1 1 2 2 3 1 2 5,6 2 3 2 2 1 2 
67 24136 2 1 1 2 2 1 2 2 1,3,5,7 4 1 2 2 1 1 
68 19090 2 3 1 1 2 1 2 2 1,4,6,7 4 1 1 2 1 1 
69 18065 1 4 1 2 3 1 3 2 1,3,4,6,7 4 1 1 2 1 1 
70 14553 2 2 2 1 3 2 3 2 4,1,2 3 3 2 3 1 1 
71 15018 2 2 2 1 3 2 2 1 2,3,5 3 3 2 3 1 1 
72 21372 2 1 2 1 2 1 4 2 1,3,5,7 4 1 1 3 1 1 
73 19681 2 1 1 2 2 1 2 2 1,2,5,6 4 1 1 3 1 1 
74 19682 1 1 1 2 2 1 2 2 2,3,4,6 4 1 1 2 1 1 
75 19950 2 2 1 1 2 1 4 1 1,5,7 3 1 2 3 1 1 
76 14409 1 1 4 2 2 2 3 2 1,2,3,4,7,7 4 3 1 1 2 0 
77 8471 2 3 1 3 2 2 2 2 1,2,4,5 4 1 1 3 1 1 
78 20650 2 2 1 2 2 1 2 2 1,7,7,7 4 1 1 2 1 1 
79 18568 2 2 1 6 2 1 2 2 1,2,3,4 4 1 1 1 1 1 
80 20666 2 3 1 5 2 2 1 2 1 1 1 3 3 1 2 
81 18735 2 2 1 4 2 1 3 1 3,5,7,7 4 2 1 2 1 1 
82 16100 2 2 1 1 2 1 3 2 1,3,4,7 4 1 1 2 1 1 
83 18140 2 2 3 1 2 1 3 2 4,6,7,7 4 1 1 1 1 1 
84 18192 2 2 4 1 2 1 3 2 1,3,4,5 4 1 1 1 2 0 
85 14742 1 1 1 2 2 1 3 1 2,4,7 3 1 2 3 1 1 
86 13908 1 1 2 1 3 1 3 1 1,3,4 3 3 1 3 1 1 
87 14811 2 1 1 2 2 2 1 2 1,4,5 3 1 1 2 1 1 
88 13490 1 1 2 1 3 1 2 2 1,7,7 3 1 1 2 1 1 
89 14675 2 1 3 1 2 4 2 1 1,5,7 3 1 1 2 1 1 
90 13981 2 1 2 1 2 1 2 1 4,5,7 3 3 2 3 1 2 
91 13987 2 1 2 4 2 1 2 1 1,3,5 3 2 1 2 1 1 
92 14199 2 1 2 1 3 1 2 1 1,5,7 3 1 2 2 1 2 
93 14454 2 1 2 1 2 1 3 1 1,4,7 3 1 1 3 1 2 
94 14409 1 1 1 2 2 1 1 2 1,2,6 3 3 2 3 1 2 
95 14407 2 1 2 1 3 1 2 2 1,3,6 3 3 2 3 1 2 
96 13908 1 1 1 2 2 2 1 2 1,2,5 3 3 2 2 1 2 
97 14742 1 1 1 2 2 2 3 2 1,2,6 3 1 2 2 1 2 
98 15367 2 1 2 6 2 1 3 1 1,2,3 3 1 2 2 1 2 
99 14354 1 1 1 2 2 2 3 1 1,3,6 3 2 2 2 1 2 
100 15201 2 1 1 2 2 2 1 2 1,2,3 3 1 1 2 1 2 
 
 
 
 
 
 
 
 
 
 
 
MASTER CHART SCALE 
 1 2 3 4 5 6 7 
Age  < 20 21-30 >30 - - - - 
Parity 1 2 3 Above 4 - - - 
Socioeconomic 
status 
V IV III II & I - - - 
Etiology Idiopathic PIH Anaemia Heart disease Placenta 
previa 
Chronic 
maternal 
disease 
Miscel 
laneous 
Weight gain < 5kgs 6-10 kgs > 11 kgs - - - - 
AFI < 5cm 5-10 cms 11-15 
cms 
> 15 cms - - - 
Doppler Normal 
flow 
Reduced 
flow 
Absent 
flow 
Reversed flow - - - 
Macroscopic 
Abnormalities 
Present Absent - - - - - 
Microscopic 
Abnormalities 
Infarct Decidual 
vasculopathy 
Syncytial 
knots 
Chorioamnionitis Stromal 
fibrosis 
Chronic 
villitis 
Miscella 
neous 
Lesions 1 2 3 Above 4 - - - 
Mode of 
Delivery 
Vaginal Instrumental LSCS - - - - 
Placental 
weight 
<350  
gms 
350-400 gms > 400 
gms 
- - - - 
Baby weight < 1.5 kgs 1.5 – 2.0 kgs 2.1 – 2.5 
kgs 
> 2.5  
kgs 
- - - 
Condition at 
Birth 
Live Still birth - - - - - 
Neonatal 
complications 
Present Absent - - - - - 
 
 
  
  
  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
